NewsBenzingaTruist Securities维持对Teladoc Health的“持有”评级,将目标价上调至9美元 Truist Securities维持对Teladoc Health的“持有”评级,将目标价上调至9美元 Benzinga 2026.11.19 13:49 (GMT+0) Open on Benzinga Other news Stifel Maintains Hold on Target, Raises Price Target to $160 Stifel Maintains Buy on BellRing Brands, Raises Price Target to $18 Guggenheim Reiterates Buy on TJX Companies, Maintains $152 Price Target Walmart's Weight-Loss Drug Windfall Is Losing Steam $1000 Invested In Charles Schwab 15 Years Ago Would Be Worth This Much Today This Aon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday